<DOC>
	<DOCNO>NCT00654589</DOCNO>
	<brief_summary>The purpose study investigate effect iron chelation use deferasirox patient show sign iron overload allogeneic stem cell transplantation The iron overload must due blood transfusion .</brief_summary>
	<brief_title>Efficacy Safety Oral Deferasirox ( 20 mg/kg/d ) Pts 3 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload</brief_title>
	<detailed_description />
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Deferasirox</mesh_term>
	<criteria>Inclusion criterion : 1 . Transfusional iron overload three six month HCT evidence active inflammation 2 . History least 20 unit red blood cell transfusion 100mL/kg prepacked red blood cell ( PRBCs ) . 3 . Patients either gender age â‰¥ 18 year . 4 . Female patient reach menarche sexually active must use doublebarrier contraception , oral contraceptive plus barrier contraception , must undergo clinically document total hysterectomy and/or ovariectomy , tubal ligation postmenopausal define amenorrhea least 12 month . Exclusion criterion : 1 . Nontransfusion relate iron overload 2 . Active malignancy 3 . Known active viral hepatitis know HIV positiveness 4 . Mean level alanine aminotransferase ( ALT ) &gt; 5x ULN 5 . Treatment iron chelator transplantation 6 . Uncontrolled systemic hypertension 7 . Serum creatinine &gt; 1.5 ULN and/or serum creatinine clearance &lt; 60 ml/min 8 . History nephrotic syndrome . 9 . Previous history clinically relevant ocular auditory toxicity relate iron chelation . 10 . Systemic disease ( cardiovascular , renal , hepatic , etc . ) would prevent patient undergo study treatment 11 . Pregnant breast feeding patient . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hematopoietic stem cell transplantation</keyword>
	<keyword>HCT</keyword>
	<keyword>iron overload</keyword>
	<keyword>chelators</keyword>
	<keyword>ICL670</keyword>
	<keyword>deferasirox</keyword>
	<keyword>serum ferritin</keyword>
	<keyword>LIC</keyword>
	<keyword>transfusional hemosiderosis</keyword>
	<keyword>blood transfusion</keyword>
	<keyword>adult</keyword>
	<keyword>iron chelation</keyword>
	<keyword>3-6 month</keyword>
	<keyword>allogeneic hematopoietic stem cell transplantation</keyword>
</DOC>